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Ethnopharmacological relevance: Trichilia catigua preparations have been popularly used in Brazil as a
tonic for the treatment of fatigue, stress, impotence, and memory deﬁcits. We recently demonstrated an
antidepressant-like effect of acute administration of the Trichilia catigua ethyl-acetate fraction (EAF) in
mice. The aim of the present study was to evaluate whether subchronic Trichilia catigua EAF
administration maintains its antidepressant-like effects and whether these effects are related to
hippocampal neurogenesis.
Material and methods: Trichilia catigua EAF (200 and 400 mg/kg) was orally administered to mice for 14
day. The animals were tested in the forced swim test (FST) or tail suspension test (TST). After behavioral
testing, the animals received bromodeoxyuridine (BrdU; 200 mg/kg, i.p.) and were euthanized 24 h,
7 day, or 15 day later. The brains were assayed for BrdU and doublecortin (DCX) immunohistochemistry
to detect cell proliferation/survival and neurogenesis, respectively.
Results: Subchronic administration of 400 mg/kg Trichilia catigua EAF promoted antidepressant-like
effects in mice in both the FST and TST. The antidepressant-like effect was accompanied by an increase
in cell proliferation in the dentate gyrus (DG) of the hippocampus 24 h after the treatments were
discontinued. This proliferative effect, however, did not inﬂuence cell survival or neurogenesis because
no change in the number of BrdU- or DCX-positive cells was detected 7 or 15 day after the last EAF
administration compared with controls.
Conclusions: Trichilia catigua EAF produced antidepressant-like effects and induced hippocampal cell
proliferation in mice. The results contribute information on the pharmacological and molecular
mechanisms involved in the antidepressant-like effect of Trichilia catigua EAF.
& 2012 Elsevier Ireland Ltd.Open access under the Elsevier OA license.1. Introduction
For many decades, the main hypothesis to explain the cause
and treatment of depression has been based on the pharmacolo-
gical effects of antidepressants on monoamine neurotransmission
(i.e., blockade of serotonin, norepinephrine, and dopamine reup-
take or breakdown; Lanni et al., 2009). However, the time lag for a
therapeutic response has led to the hypothesis that cellular
and molecular adaptations to the actions of antidepressants occur
and are necessary for their antidepressant effects. Alterations
in cell morphology, the length and complexity of neuronal
processes, and the birth of new neurons in the hippocampusx: þ55 44 3011 4999.
e Oliveira).
der the Elsevier OA license.(i.e., neurogenesis) have been associated with the action of
antidepressants. Various antidepressants, including tricyclic anti-
depressants and selective serotonin reuptake inhibitors, increase
neuronal proliferation in the hippocampal dentate gyrus (DG) in
adult rodents that receive chronic treatment (Malberg et al.,
2000; Malberg, 2004). Antidepressant-induced neurogenesis
occurs over 2–4 weeks, a time scale that corresponds to the
therapeutic delay typically seen in clinical treatment (Malberg
et al., 2000). Therefore, demonstrating increased hippocampal
neurogenesis induced by a novel compound has been considered
one way to validate the compound’s antidepressant effects
(Malberg, 2004).
Trichilia catigua Juss (Meliaceae) is a medium-sized ﬂowering
tree widely distributed in South American countries. In Brazil, it is
known as ‘‘catuaba’’, ‘‘catuama,’’ and ‘‘catigua´’’ and has been used
in folk medicine as a tonic for the treatment of fatigue, stress,
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Campos et al. (2005). demonstrated the antidepressant-like
effects of a Trichilia catigua hydroethanolic extract in rodents
subjected to the forced swim test (FST). The antidepressant-like
effects of Trichilia catigua were mainly associated with the
modulation of the dopaminergic system, based on the fact that
two dopamine receptor antagonists, haloperidol and chlorproma-
zine, completely reversed the effects of Trichilia catigua in the FST
in rats. We recently demonstrated an antidepressant-like effect of
acute administration of the Trichilia catigua ethyl-acetate fraction
(EAF) in mice. In addition to its antidepressant-like effects,
Trichilia catigua EAF improved cognition in an inhibitory avoid-
ance task (i.e., the step-down task; Chassot et al., 2011).
Given that hippocampal neurogenesis has been associated
with memory improvements (Deng et al., 2010) and antidepres-
sant-like effects (Sahay et al., 2007), the aim of the present study
was to test whether subchronic Trichilia catigua EAF administra-
tion has antidepressant-like effects and whether these effects are
related to hippocampal neurogenesis.2. Material and methods
2.1. Plant material and extract preparation
The bark of Trichilia catigua was acquired in Caetite´, Bahia,
Brazil, in 2008, and a voucher specimen was identiﬁed by
Dr. Ca´ssia Moˆnica Sakuragui, Universidade Federal do Rio de
Janeiro, RJ, Brazil, and deposited at the Herbarium of Universidade
Estadual de Maringa´ (no. 19.434), Maringa´, PR, Brazil. The extracts
were produced as described by Chassot et al. (2011). Brieﬂy, the
crude extract (CE) was produced with acetone–water (7:3; v/v) to
yield 101 g from 450 g of bark. The semipuriﬁed EAF was obtained
after partition with ethyl acetate to yield 13 g from 50 g of CE.
2.2. Animals
Male Swiss mice, weighing 30–40 g, were housed in groups
(n¼5 per group) with food and water freely available and
maintained at 2272 1C under a 12 h/12 h light/dark cycle. All of
the procedures were conducted in accordance with the Brazilian
College of Animal Experimentation (COBEA), which comply with
international laws, and were approved by the Ethics Committee
on Animal Experimentation of the State University of Maringa´
(CEEA 042/2007).
2.3. Treatments
Saline, 20 mg/kg imipramine (Sigma-Aldrich, St. Louis, MO,
USA), and 200 and 400 mg/kg EAF were administered orally by
gavage in a volume of 10 ml/kg using a tuberculin syringe ﬁtted
with an oral cannula (0.1 cm4 cm). The treatments were
administered once per day for 14 consecutive days. The doses of
EAF were based on a previous study that found antidepressant-
like effects of a single EAF administration in mice (Chassot et al.,
2011).
2.4. Behavioral testing
One hour after the last administration, the animals were
subjected to the FST. A separate group of animals was evaluated
in the tail suspension test (TST). Behavioral testing was performed
in a dark room with minimal background noise. Hand-operated
counters and stopwatches were used by a blind observer to score
the behavioral parameters.Forced swim test. The FST was performed according to the
methods described by Porsolt et al. (1977). Brieﬂy, the mice were
gently and individually placed in a glass beaker (25 cm
height10 cm diameter) that contained 2372 1C water that
was deep enough so that the mice could not touch the bottom
of the container or escape. The amount of time the mouse spent
active until its ﬁrst immobility episode (i.e., latency) and immo-
bility time, during which the mouse did not struggle and made
only movements necessary to keep its head above water, were
measured during a 6 min swimming session. Immobility time was
measured during the last 4 min of the session.
Tail suspension test. The TST was conducted as previously
described by Steru et al. (1985) with slight modiﬁcations. A
mouse was individually suspended by its tail with adhesive tape
(1 cm from the tip of the tail) in a black wooden box
(45 cm45 cm30 cm) for 6 min. The mouse was considered
immobile only when it hung passively and completely motion-
less. Immobility time was measured during the last 4 min of the
session.
2.5. Histological procedures
Immediately after behavioral testing in the FST, all of the mice
received the thymidine analog 5-bromo-2-deoxyuridine (BrdU;
Sigma-Aldrich, St. Louis, MO, USA) intraperitoneally at 200 mg/kg,
divided into four injections 2 h apart. To observe the effects of the
treatments on neuronal proliferation, a group of animals (n¼4–6)
was sacriﬁced 24 h after BrdU administration. To verify the
survival of proliferating cells (BrdU), subgroups of animals
(n¼4–7) were sacriﬁced 7 or 15 day after the last BrdU admin-
istration. Neurogenesis was conﬁrmed by immunohistochemistry
using the antibody anti-microtubule-associated protein double-
cortin (DCX), which is expressed transiently in newly generated
neurons, 24 h and, 7 and 15 day after the treatments.
Twenty-four hours, 7 day, or 15 day after the last BrdU
administration, the mice were deeply anesthetized with an over-
dose of sodium thiopental (Thiopentax, Crista´lia, SP, Brazil) and
transcardially perfused with saline followed by 4% paraformalde-
hyde in 0.01 M phosphate-buffered saline (PBS). The brains were
removed, post-ﬁxed for 2 h in the same ﬁxative, and cryopro-
tected by immersion in 30% sucrose for 48 h. Thereafter, frozen
tissue was serially sectioned on a cryostat (Criocut 1800, Reich-
ert-Jung, Heidelberg, Germany) into 40 mm coronal sections and
collected in quadruplicate in Eppendorf tubes that contained anti-
freeze solution. The sections were then processed for BrdU or DCX
immunohistochemistry to evaluate cell proliferation and neuro-
genesis, respectively.
Immunohistochemistry. For BrdU immunohistochemistry, the
sections were ﬁrst digested in 0.005% trypsin for 5 min at 37 1C,
incubated in 1 N HCl for 75 min at 40 1C for DNA denaturation,
and neutralized with 0.1 M borate buffer (pH 8.5). Afterward, all
of the sections were quenched in 1% H2O2 for 30 min and then
blocked with 2% bovine serum albumin in PBS for 60 min. The
sections were incubated with rat monoclonal anti-BrdU antibody
(1:100; Santa Cruz Biotechnology, Santa Cruz, CA, USA) or goat
polyclonal anti-DCX antibody (1:400; AbCam, St. Louis, MO, USA)
in PBS that contained 0.3% Triton X-100 for 48 h at room
temperature. The sections were then incubated with respective
biotinylated secondary antibodies (1:500) for 2 h at room tem-
perature. The sections were further incubated in ABC solution
(Vectastain Elite ABC Kit, Vector Laboratories, Burlingame, CA,
USA) for 2 h. The peroxidase reaction was performed by incubat-
ing the sections with 3-30-diaminobenzidine (DAB; Sigma) and
0.05% H2O2. The sections were mounted onto gelatin-coated
slides, air dried, cleared with xylene, and coverslipped with
Permount.
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randomized and coded prior to quantitative analysis. BrdU- and DCX-
positive cells were scored in the DG under 40 or 100 magniﬁca-
tion, respectively, in both brain hemispheres using an optical micro-
scope (Olympus Optical, BX50, Center Valley, PA, USA).
For BrdU counting, six to eight coronal sections, spaced
160 mm apart and corresponding to the whole hippocampal
extension, 1.06 to 3.64 mm from bregma (Franklin and
Paxinos, 1997), were analyzed. Doublecortin-positive cells in the
DG were counted in three brain sections per animal, correspond-
ing to the coronal coordinates 1.58 to 2.30 mm from bregma
(Schiavon et al., 2010). The data are expressed as the mean
number of positive cells in both cerebral hemispheres.
2.6. Statistical analysis
The data are expressed as the mean7SEM of the experimental
groups. Differences amongmeans were analyzed by one-way analysis
of variance (ANOVA), followed by the Newman Keuls post-hoc test.
Values of po0.05 were considered statistically signiﬁcant.3. Results
3.1. Subchronic administration of 400 mg/kg Trichilia catigua EAF
exerts antidepressant-like effects
Subchronic administration of 20 mg/kg imipramine and
400 mg/kg Trichilia catigua EAF decreased immobility time in
the FST compared with the saline group (F3,42¼12.1, po0.0001).
No signiﬁcant effect was observed in mice that received 200 mg/kg
Trichilia catigua EAF (p40.05). No difference was detected among
the experimental groups in the latency to the ﬁrst immobility
episode (F3,42¼1.99, p¼0.13; Fig. 1A).
The antidepressant-like effects of 20 mg/kg imipramine and
400 mg/kg Trichilia catigua EAF were conﬁrmed in the TST
(F2,29¼20.10, po0.0001), reﬂected by a signiﬁcant decrease in
immobility time in the EAF group compared with the saline group
(Fig. 1B). No signiﬁcant effect on latency was observed in any of
the experimental groups (F2,26¼0.54, p¼0.59).
3.2. Subchronic administration of 400 mg/kg Trichilia catigua EAF
increased hippocampal cell proliferation
An enhanced number of BrdU-positive cells was observed
24 h after BrdU administration in both the imipramine- andFig. 1. Imipramine and Trichilia catigua EAF reduced immobility time in mice subjecte
(20 mg/kg), Trichilia catigua EAF (200 and 400 mg/kg), or saline were orally administer
in the FST or TST. The latency and immobility time were recorded during the last 4 m
(ANOVA followed by Newman Keuls post-hoc test).Trichilia catigua EAF-treated groups compared with controls
(F2,14¼18.76, p¼0.0002; Fig. 2A), indicating an increase in cell
proliferation. BrdU-positive cells were observed predominately in
the deepest layers of the subgranular zone (SGZ) and hilus of the
hippocampal DG. BrdU-positive nuclei appeared as dark and uniform
staining with various shapes and frequently in clusters (Fig. 2B).
3.3. Subchronic treatment with 400 mg/kg Trichilia catigua EAF
did not affect cell survival or hippocampal neurogenesis
As shown in Fig. 3A, the signiﬁcant increase in the number of
BrdU-positive cells induced by imipramine continued for 7 day
(F2,14¼7.59, p¼0.007) and 15 day (F2,19¼5.30, p¼0.002), suggest-
ing that the neurons that incorporated BrdU after the treatments
survived until these times. At 7 and 15 day, BrdU-positive cells
appeared isolated, with a more rounded shape and integrating the
hippocampal granular cell layer (Fig. 3B).
Immunohistochemical staining revealed the presence of DCX-
positive neurons in the granule cell layer and SGZ of the DG in all
of the groups (Fig. 4B). However, no signiﬁcant differences were
observed in the number of DCX-positive cells among the groups
24 h (F2,14¼0.16, p¼0.85) 7 (F2,13¼0.69, p¼0.52) or 15 day
(F2,14¼0.65, p¼0.540) after the treatments (Fig. 4A).4. Discussion
The present study showed that subchronic administration of
400 mg/kg Trichilia catigua EAF induced antidepressant-like
effects in mice in the FST and TST. The antidepressant-like effect
of EAF was accompanied by an increase in cell proliferation in the
DG of the hippocampus 24 h after the treatments were discon-
tinued. This proliferative effect, however, did not inﬂuence cell
survival or neurogenesis because no change in the number of
BrdU- or DCX-positive cells was detected 24 h, 7 or 15 day after
the last EAF administration.
The FST and TST are widely used as animal models to screen
potential antidepressants (Cryan et al., 2005; Porsolt et al., 1977).
Both tests are based on the observation that rodents, following
escape-oriented movements, develop immobility. Thus, immobi-
lity or behavioral ‘‘despair’’ exhibited in both the FST and TST has
been accepted as an animal model of depression, in which anti-
depressant drugs reduce immobility time. In the present work,
subchronic Trichilia catigua EAF administration decreased immo-
bility in both the FST and TST, indicating an antidepressant-like
effect of this treatment. The effects of Trichilia catigua EAF wered to the (A) forced swim test (FST) and (B) tail suspension test (TST). Imipramine
ed to mice for 14 day. One hour after the last treatment, the animals were tested
in of the experimental sessions. npo0.05, And **po0.001, compared with saline
Fig. 3. Effect of subchronic treatment with 20 mg/kg imipramine or 400 mg/kg Trichilia catigua EAF on the number of BrdU-positive cells 7 and 15 day after the end of the
treatments. (A) Number of BrdU-positive cells in the granular layer (GL) of the DG. Bars represent the mean7SEM. *po0.05, **po0.001, Compared with control group
(ANOVA followed by Neuman Keuls post-hoc test). (B) Representative diagram (modiﬁed from Franklin and Paxinos, 1997) that shows the GL (red). (C) Representative
photomicrographs show BrdU-positive cells in the (C) saline, (D) 20 mg/kg imipramine, and (E) 400 mg/kg Trichilia catigua EAF groups. Notice that BrdU-positive cells
present a rounded shape and are integrated in the granular cell layer (GCL). Scale bar¼20 mm. (For interpretation of the references to color in this ﬁgure legend, the reader
is referred to the web version of this article.)
Fig. 4. (A) Number of doublecortin (DCX)-positive cells in the DG in the experimental groups 24 h, 7 and 15 day after the end of the treatments. Bars represent the
mean7SEM. (B) Representative photomicrograph of the DG with DCX-positive cells from a control brain. Representative photomicrographs show DCX-positive cells in the
(C) saline, (D) 20 mg/kg imipramine, and (E) 400 mg/kg Trichilia catigua EAF groups 15 day after treatments. Scale bar¼100 mm.
Fig. 2. Subchronic treatment with 400 mg/kg Trichilia catigua EAF increase cell proliferation in the subgranular zone (SGZ) of the dentate gyrus (DG) in mice. (A) Number of
BrdU-positive cells in the SGZ of the DG 24 h after the last treatment administration. Bars represent the mean7SEM. *po0.05, **po0.001, Compared with control group
(ANOVA followed by Neuman Keuls post-hoc test). (B) Representative diagram (modiﬁed from Franklin and Paxinos, 1997) that shows the SGZ. Representative
photomicrographs show BrdU-positive cells in the (C) saline, (D) 20 mg/kg imipramine, and (E) 400 mg/kg Trichilia catigua EAF groups. Notice that the majority of BrdU-
positive cells are located in the SGZ and frequently appear in clusters. Scale bar¼100 mm. (For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the web version of this article.)
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pressant imipramine. Although inferring which active compounds
are involved in the observed antidepressant-like effects of Trichilia
catigua EAF is not possible in the present study, chemical studieshave indicated the presence of the phenylpropanoid-substituted
epicatechins catiguanin A and catiguanin B and cinchonains Ia, Ib,
Ic, and Id in the bark of Trichilia catigua (Beltrame et al., 2006; Tang
et al., 2007). These compounds exerted potent antioxidant activity
V. Taciany Bonassoli et al. / Journal of Ethnopharmacology 143 (2012) 179–184 183that was related to the neuroprotective effects and neuritogenic
properties of catechins and cinchonains (Weinreb et al., 2009). It is
possible that the antidepressant-like effect of Trichilia catigua EAF
may be related to antioxidant and neuroplastic activity.
The behavioral effects of Trichilia catigua EAF were further
characterized by immunohistochemistry, showing that Trichilia
catigua EAF also enhanced cell proliferation in the hippocampus,
an index of antidepressant-like activity. We compared the pro-
liferation and survival of newborn cells in the DG in mice treated
with imipramine and Trichilia catigua EAF using immunohisto-
chemistry to detect BrdU, a thymidine analog that can be retained
within cells during division (Huang and Herbert, 2006). BrdU was
administered after Trichilia catigua EAF, and the number of BrdU-
positive cells was measured 24 h, 7 day, and 15 day later.
Imipramine and Trichilia catigua EAF increased the number of
BrdU-positive cells in the DG 24 h after the last administration.
This ﬁnding indicates an increase in cell proliferation induced by
these treatments. However, tracking BrdU-positive cells 7 and
15 day post-treatment, we observed no signiﬁcant differences in
the number of BrdU-positive cells between the Trichilia catigua
EAF- and saline-treated groups, indicating that subchronic Trichi-
lia catigua EAF treatment did not inﬂuence cell survival. Increased
granule cell proliferation induced by antidepressant treatments
indicates that more competing neurons are available for selection,
which may improve the ability of the hippocampus to adapt to
emerging environmental challenges. This phenomenon might
play a role in the beneﬁcial clinical effects of antidepressant
treatments (Von Bohlen and Halbach, 2011).
Concerning the experiment that focused on cell survival, a
decrease in the number of BrdU-positive cells was observed over
time in all of the experimental groups, including the control
group. This ﬁnding is consistent with loss caused by cell death or
BrdU dilution through repeated rounds of mitosis (Bingham et al.,
2005). Regardless of the reason for the decrease in the number of
BrdU-labeled cells, the cells that remained beyond 7 and 15 day
post-treatment were localized to the granular cell layer of the DG,
indicating that these cells survived after BrdU administration. The
detection and speciﬁc localization of BrdU-positive cells in the
granular cell layer of the DG is a strong indicator of the neuronal
phenotype of newborn cells. As expected, in addition to increas-
ing cell proliferation, imipramine also enhanced the survival of
postmitotic cells, conﬁrming its antidepressant-like properties.
To conﬁrm the effects of Trichilia catigua EAF treatment on
hippocampal neurogenesis, we also performed immunohisto-
chemistry to detect DCX-positive neurons. Doublecortin is a
protein that promotes microtubule polymerization (Francis
et al., 1999). Its expression is thought to be speciﬁc to newly
generated neurons because virtually all DCX-positive cells express
early neuronal antigen but lack antigens speciﬁc to glia, undiffer-
entiated cells, and apoptotic cells (Rao and Shetty, 2004). Dou-
blecortin expression begins shortly after the neurons are born and
persists for approximately 2 weeks in rats and 3 weeks in mice.
Doublecortin expression then gradually declines as the neurons
continue to mature (Rao and Shetty, 2004; Snyder et al., 2009). In
the present study, no signiﬁcant difference in the number of
DCX-positive cells was observed in mice treated with imipramine
or Trichilia catigua EAF. Unexpectedly, imipramine treatment for
14 day did not change the number of DCX-positive neurons
compared with controls, although the treatment regimen used
here was similar to previous studies showing positive effects of
imipramine on DCX expression (Murray et al., 2008; Schiavon
et al., 2010). The reason for the lack of effect of imipramine on
the survival of newborn neurons is unknown. However, previous
research showed that imipramine may induce neurogenesis only
after 3 weeks of administration (Pechnick et al., 2008; Sairanen
et al., 2005). Therefore, the imipramine and Trichilia catiguaEAF treatment duration may not have been sufﬁcient to promote
a signiﬁcant increase in neurogenesis in the DG of the hippocam-
pus. Further studies with longer administration periods and other
doses of imipramine and Trichilia catigua EAF need to be con-
ducted to resolve this issue.
In conclusion, the present results demonstrated that 400 mg/
kg Trichilia catigua EAF produced antidepressant-like effects in the
FST and TST and increased cell proliferation in the hippocampal
DG. The results provide information on the pharmacological and
molecular mechanisms involved in the antidepressant-like effect
of Trichilia catigua EAF and implicate its potential as a coadjuvant
treatment for mood disorders.Acknowledgments
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